Portal de Periódicos da CAPES

YKL‐40 expression in anal carcinoma predicts shorter overall and disease‐free survival

2009; Wiley; Volume: 55; Issue: 2 Linguagem: Inglês

10.1111/j.1365-2559.2009.03364.x

1365-2559

Isabella Castellano, Massimiliano Mistrangelo, Valentina Crudo, Luigi Chiusa, R. Lupo, Umberto Ricardi, Mario Morino, Antonio Mussa, Paola Cassoni,

Galectins and Cancer Biology

HistopathologyVolume 55, Issue 2 p. 238-240 YKL-40 expression in anal carcinoma predicts shorter overall and disease-free survival Isabella Castellano, Isabella Castellano Department of Biomedical Sciences and Human OncologySearch for more papers by this authorMassimiliano Mistrangelo, Massimiliano Mistrangelo Department of Surgery and Centre of Minimal Invasive SurgerySearch for more papers by this authorValentina Crudo, Valentina Crudo Department of Biomedical Sciences and Human OncologySearch for more papers by this authorLuigi Chiusa, Luigi Chiusa Department of Biomedical Sciences and Human OncologySearch for more papers by this authorRosanna Lupo, Rosanna Lupo Department of Biomedical Sciences and Human OncologySearch for more papers by this authorUmberto Ricardi, Umberto Ricardi Department of RadiotherapySearch for more papers by this authorMario Morino, Mario Morino Department of Surgery and Centre of Minimal Invasive SurgerySearch for more papers by this authorAntonio Mussa, Antonio Mussa Oncological Surgical Department, University of Turin, Turin, ItalySearch for more papers by this authorPaola Cassoni, Paola Cassoni Department of Biomedical Sciences and Human OncologySearch for more papers by this author Isabella Castellano, Isabella Castellano Department of Biomedical Sciences and Human OncologySearch for more papers by this authorMassimiliano Mistrangelo, Massimiliano Mistrangelo Department of Surgery and Centre of Minimal Invasive SurgerySearch for more papers by this authorValentina Crudo, Valentina Crudo Department of Biomedical Sciences and Human OncologySearch for more papers by this authorLuigi Chiusa, Luigi Chiusa Department of Biomedical Sciences and Human OncologySearch for more papers by this authorRosanna Lupo, Rosanna Lupo Department of Biomedical Sciences and Human OncologySearch for more papers by this authorUmberto Ricardi, Umberto Ricardi Department of RadiotherapySearch for more papers by this authorMario Morino, Mario Morino Department of Surgery and Centre of Minimal Invasive SurgerySearch for more papers by this authorAntonio Mussa, Antonio Mussa Oncological Surgical Department, University of Turin, Turin, ItalySearch for more papers by this authorPaola Cassoni, Paola Cassoni Department of Biomedical Sciences and Human OncologySearch for more papers by this author First published: 30 July 2009 https://doi.org/10.1111/j.1365-2559.2009.03364.xCitations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Allal AS, Waelchli L, Brundler MA. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma. Clin. Cancer Res. 2003; 9; 6489–6496. 2 Clancy R. Nitric oxide alters chondrocyte function by disrupting cytoskeletal signaling complexes. Osteoarthritis Cartilage 1999; 7; 399–400. 3 De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem. Biophys. Res. Commun. 2001; 285; 926–931. 4 Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann. Rheum. Dis. 2001; 60; 619–626. 5 Nordenbaek C, Johansen JS, Junker P, Borregaard N, Sorensen O, Price PA. YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J. Infect. Dis. 1999; 180; 1722–1726. 6 Volck B, Price PA, Johansen JS et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc. Assoc. Am. Physicians 1998; 110; 351–360. 7 Roslind A, Johansen JS, Christensen IJ et al. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival. Int. J. Cancer 2008; 122; 857–863. 8 Cintin C, Johansen JS, Christensen IJ, Price PA, Sorensen S, Nielsen HJ. Serum YKL-40 and colorectal cancer. Br. J. Cancer 1999; 79; 1494–1499. 9 Hogdall EV, Johansen JS, Kjaer SK et al. High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Oncol. Rep. 2003; 10; 1535–1538. 10 Dehn H, Hogdall EV, Johansen JS et al. Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer. Acta Obstet. Gynecol. Scand. 2003; 82; 287–293. 11 Johansen JS, Christensen IJ, Riisbro R et al. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res. Treat. 2003; 80; 15–21. 12 Jensen BV, Johansen JS, Price PA. High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin. Cancer Res. 2003; 9; 4423–4434. 13 Pelloski CE, Mahajan A, Maor M et al. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin. Cancer Res. 2005; 11; 3326–3334. Citing Literature Volume55, Issue2August 2009Pages 238-240 ReferencesRelatedInformation